RESUMEN
An outbreak of a respiratory sickness started in Wuhan, China in December 2019 and the causative agent was found be a novel betacoronovirus of the same subgenus as SARSCoV and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19) quickly spread around the world, with clinical signs ranging from mild respiratory symptoms to severe pneumonia and a fatality rate estimated around 2%. Lower respiratory tract infections can occur in immunocompromised subjects and the elderly persons. Respiratory droplets are the causative agent for the person-to-person spread of the disease resembling the spread of influenza. Individual to individual spread turned into the primary mode of transmission. The transmission of the disease might be more likely in the earlier stage of infection as the viral RNA levels appear to be higher. Accurate diagnosis in the early stages of the epidemic helps control the spread of the disease. [ FROM AUTHOR] Copyright of Indian Drugs is the property of Indian Drug Manufacturers' Association (IDMA) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)